HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.6567
-0.0033 (-0.50%)
At close: Mar 4, 2026, 4:00 PM EST
0.6709
+0.0142 (2.16%)
Pre-market: Mar 5, 2026, 8:00 AM EST

HCW Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.14.673.622.3311.738.46
Short-Term Investments
---9.7424.98-
Cash & Short-Term Investments
1.14.673.632.0636.718.46
Cash Growth
9.89%30.03%-88.79%-12.67%334.19%14.95%
Accounts Receivable
0.030.581.540.420.132.5
Other Current Assets
0.460.441.271.593.631.19
Total Current Assets
1.595.76.434.0740.4812.15
Net Property, Plant & Equipment
22.522.9120.4510.81.121.62
Long-Term Investments
1.331.61.61.611.521.6
Other Long-Term Assets
0.030.030.060.330.390.03
Total Assets
25.4530.2428.5146.8153.5115.4
Accounts Payable
18.9722.336.171.230.220.16
Accrued Expenses
1.080.982.581.732.10.85
Short-Term Debt
6.816.31----
Total Current Liabilities
26.8629.638.752.962.321
Long-Term Debt
-7.386.36.41--
Other Long-Term Liabilities
0.69--0.01--
Total Long-Term Liabilities
0.697.386.36.42--
Total Liabilities
27.5537.0115.059.382.321
Common Stock
000000
Additional Paid-in Capital
107.1393.7983.9982.9681.83-
Retained Earnings
-109.24-100.56-70.53-45.54-30.64-16.72
Total Common Shareholders' Equity
-2.11-6.7713.4637.4351.19-16.72
Minority Interest
-----31.12
Shareholders' Equity
-2.11-6.7713.4637.4351.1914.4
Total Liabilities & Equity
25.4530.2428.5146.8153.5115.4
Total Debt
6.8113.696.36.4100
Net Cash (Debt)
-5.71-9.02-2.7125.6536.718.46
Net Cash Growth
----30.13%334.19%14.95%
Net Cash Per Share
-3.68-9.30-3.0228.6478.2471.37
Book Value
-2.11-6.7713.4637.4351.19-16.72
Book Value Per Share
-1.36-6.9814.9941.79109.09-141.10
Tangible Book Value
-2.11-6.7713.4637.4351.19-16.72
Tangible Book Value Per Share
-1.36-6.9814.9941.79109.09-141.10
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q